Kiniksa Pharmaceuticals
KNSA
KNSA
102 hedge funds and large institutions have $402M invested in Kiniksa Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less capital invested
Capital invested by funds: $537M → $402M (-$135M)
34% less call options, than puts
Call options by funds: $2.87M | Put options by funds: $4.33M
Holders
102
Holding in Top 10
–
Calls
$2.87M
Puts
$4.33M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$11.8M | |
| 3 | +$11.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.58M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$5.57M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$24.6M | |
| 3 | -$12.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.07M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.27M |